NanoViricides
NNVC • AMEX
NanoViricides is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Anil R. Diwan, with a market cap of $22.9M.
Market Cap$22.9M
Employees7.0
CEOAnil R. Diwan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ3 2026
Financials
NNV
NanoViricides FAQ
Common questions about NanoViricides
NanoViricides is scheduled to report earnings for Q3 2026 on May 14, 2026.
NanoViricides has approximately 7 employees.